RECORD OF PROCEEDINGS
PHYSICAL DISABILITY BOARD OF REVIEW
BRANCH OF SERVICE: ARMY
SEPARATION DATE: 20031120
NAME: XXXXXXXXXXXXXXXXX
CASE NUMBER: PD1200621
BOARD DATE: 20121113
SUMMARY OF CASE: Data extracted from the available evidence of record reflects that this
covered individual (CI) was an active duty SSG/E-6 (11M10/Fighting Vehicle Infantryman),
medically separated for an asthma condition. The CI did not improve adequately with
treatment to satisfy physical fitness standards. The CI developed shortness of breath and
coughing with mild exertion and exercise intolerance. He was prescribed Advair twice a day
and Albuterol as needed. He was issued a permanent P3 profile and referred for a Medical
Evaluation Board (MEB). The MEB was returned for reconsideration and additional testing and
a NARSUM addendum were considered by the MEB. The asthma condition was forwarded to
the Physical Evaluation Board (PEB) as medically unacceptable IAW AR40-501, chpt 3-27c. The
MEB forwarded no other conditions for PEB adjudication. The PEB adjudicated the asthma
condition as unfitting “with CHCS/Pharmacy record noting intermittent use - no medications
from April 2003 until July 2003”, rated 10%, with application of the Veteran’s Affairs Schedule
for Rating Disabilities (VASRD). The CI made no appeals, and was medically separated with a
10% disability rating.
CI CONTENTION: “The VA has my rating at 80% for service connected disabilities. The Army
never addressed all of my conditions. I was pressured to get out seven years before retirement.
I was told that I would never make E-7. I wanted to stay until retirement.”
SCOPE OF REVIEW: The Board wishes to clarify that the scope of its review as defined in DoDI
6040.44, Enclosure 3, paragraph 5.e. (2) is limited to those conditions which were determined
by the PEB to be specifically unfitting for continued military service; or, when requested by the
CI, those condition(s) “identified but not determined to be unfitting by the PEB.” The ratings
for unfitting conditions will be reviewed in all cases. The asthma condition requested for
consideration meets the criteria prescribed in DoDI 6040.44 for Board purview, and is
accordingly addressed below. The other unspecified requested conditions are not within the
Board’s purview. Any conditions or contention not requested in this application, or otherwise
outside the Board’s defined scope of review, remain eligible for future consideration by the
Army Board for Correction of Military Records.
RATING COMPARISON:
Service IPEB – Dated 20030829
VA (4 Mos. Post-Separation) – All Effective Date 20031121
Condition
Asthma
Code
6602
Rating
10%
No Additional MEB/PEB Entries
Condition
Bronchial Asthma
Patellofemoral, Syndrome, R Knee
Patellofemoral, Syndrome, L Knee
Tinnitus
Code
6602
5014
5014
6260
Rating
10%*
10%
10%
10%
Exam
20040324
20040324
20040324
20040324
Combined: 10%
0% X 1 / Not Service-Connected x 1
Combined: 40%
20040324
*Asthma increased to 30% effective 20090316 (combined 80%)
ANALYSIS SUMMARY: The Board acknowledges the CI's contention suggesting that ratings
should have been conferred for other conditions documented at the time of separation and for
conditions not diagnosed while in the Army (but later determined to be service-connected by
the VA). While the Disability Evaluation System (DES) considers all of the member's medical
conditions, compensation can only be offered for those medical conditions that cut short a
member’s career, and then only to the degree of severity present at the time of final
disposition. The Department of Veterans Affairs (DVA), however, is empowered to compensate
service-connected conditions and to periodically re-evaluate said conditions for the purpose of
adjusting the Veteran’s disability rating should the degree of impairment vary over time. The
Board also acknowledges the CI’s assertions that he was pressured to separate before
retirement. It is noted for the record that the Board has neither the jurisdiction nor authority
to scrutinize or render opinions in reference to asserted improprieties in the disposition of a
case. The Board’s role is confined to the review of medical records and all evidence at hand to
assess the fairness of PEB rating determinations, compared to VASRD standards, based on
severity at the time of separation. It must also judge the fairness of PEB fitness adjudications
based on the fitness consequences of conditions as they existed at the time of separation.
Asthma Condition. The pulmonary and pulmonary function test (PFTs) evaluations in evidence,
which the Board weighed in arriving at its rating recommendation, with documentation of
additional ratable criteria, are summarized in the chart below.
Pulmonary Exam
FEV1 (% Predicted)
FEV1/FVC
Meds
~5 Mo. Pre-Sep
MEB Addendum ~4 Mo. Pre-Sep
VA C&P ~7 Mo. Post-Sep
76%
85%
Ref 5 Mo. Pre-Sep PFTs
Albuterol as needed,
Advair twice daily;
1 course systemic steroids
past year
Advair(dose increased) twice
daily, Albuterol as needed,
Optimally managed…current
medication course
--
--
Advair twice daily, Albuterol as
needed, Allegra daily; fine
expiratory wheezes bilat
§4.97 Rating
30%
30% (PEB 10%)
30% (VA 10%)
The CI presented with exercise intolerance in October 2002, a year prior to separation. He was
treated with inhaled Advair (artificial steroid, w/ anti-inflammatory) twice daily and inhaled
Albuterol (bronchodilator) as needed “but was still unable to perform running and heavy
exertional activities.” He was placed on a P3 profile which triggered the MEB. At the MEB
exam, performed 8 months prior to separation, the CI reported some improvement in his
shortness of breath and cough with medications, but continued exercise and heavy exertional
activity intolerance. The MEB physical exam noted normal lung exam, and a post-
bronchodilator FEV of 79%. His medications were Advair twice daily and Albuterol as needed.
The MEB Addendum 5 months prior to separation described the asthma condition as
“moderate in nature and being optimally managed on the patient’s current medications” and
PFTs as described above. The CI was also evaluated for paradoxical vocal cord dysfunction
(including bronchoscopy in June 2003), which was “stable and not amenable to further
treatment.” The service treatment records (STR) documented several visits to the CHMC with
complaints of shortness of breath and activity intolerance. The STR also documented receipt of
nebulizer treatments and prescription refills at the CHMC.
At the VA examination, performed 7 months after separation, the CI reported daily inhaler use.
The physical exam demonstrated fine expiratory wheezes bilaterally in posterior lung fields.
PFTs were stated as pending, with no VA PFTs proximate to that exam date in evidence. The
Board directs attention to its rating recommendation based on the above evidence. The VA
rated the asthma at 10% coded 6602, however the exam and rating narrative indicated daily
inhaled medication use (including an artificial steroid). [VARD “Your VA examination shows
your therapy consists of three different inhaled medications on a daily basis. You last used oral
steroids in January 2003. You have daily wheeze and cough. Examination of the lungs revealed
fine expiratory wheezes bilaterally. Service connection for bronchial asthma is granted with an
evaluation of 10 percent disabling effective 23 November 2003, date following discharge.”]
The PEB’s DA Form 199 disability description “Asthma with CHCS/Pharmacy record noting
intermittent use - no medications from April 2003 until July 2003” makes it clear that its 10%
rating for asthma was derived from the VASRD, without daily medication use (“CHCS/Pharmacy
record noting intermittent use”). It is clear that the CI’s PFTs would not justify a rating higher
than 10%. The use of daily inhaled corticosteroids and bronchodilators would justify a rating of
30%. The key question to the Board was whether there was reasonable doubt as to the CI’s
severity based on medication use.
The CI was seen by military and private physicians. All treatment notes and the VA exam
indicated daily inhaled medication use. The CI was treated with oral steroids by a private
physician which was noted in the service asthma outpatient documentation, but no oral steroid
medication was noted in the CHCS/Pharmacy record medication profile. The CI was also
treated with Nystatin for oral thrush in June 2003. Oral thrush is not usually seen in adults
except with immune suppression (chronic systemic steroid use or diseases), or as most likely in
this case the use of inhaled corticosteroids when used without ideal technique (inhaled
medication deposits too much in the mouth).
The Board discussed at length the probative value of the treatment records indicating daily
medication use and the CHCS/Pharmacy record documenting no CHCS dispensed inhaled
controller medication for a 4-month period adjudged by the PEB to indicate intermittent
inhaled medication use. Given the CI’s prescribed Advair dosing of one puff twice a day, two
canisters of Advair from any source not captured by the CHCS/Pharmacy record medication
profile would cover that timeframe. The Board considered that the CHCS/Pharmacy record did
not include the oral steroids that were clearly prescribed by a civilian physician and per multiple
treatment records were taken by the CI. The Board also noted that CHCS/Pharmacy records,
especially in 2003, did not include any civilian pharmacy provided medication or medications
issued from outside the main pharmacy such as clinic medication cabinets, emergency
departments/inpatient sources (such as pulmonary testing labs or bronchoscope labs), or from
civilian provider’s direct dispensing from samples or other sources.
After review of the entirety of the evidence on the CI’s medication history, the Board majority
determined that there was reasonable evidence that the CI had access to multiple providers for
his prescriptions which were very likely not reflected in the CHCS/Pharmacy record medication
profile. All treatment notes and histories indicated “daily inhalational or oral bronchodilator
therapy, or; inhalational anti-inflammatory medication” which met the 30% rating criteria.
After due deliberation, considering all of the evidence and mindful of VASRD §4.3 (reasonable
doubt), the Board majority recommends a disability rating of 30% for the asthma condition.
BOARD FINDINGS: IAW DoDI 6040.44, provisions of DoD or Military Department regulations or
guidelines relied upon by the PEB will not be considered by the Board to the extent they were
inconsistent with the VASRD in effect at the time of the adjudication. The Board did not
surmise from the record or PEB ruling in this case that any prerogatives outside the VASRD
were exercised. In the matter of the asthma condition, the Board by a vote of 2:1, recommends
a disability rating of 30%, coded 6602 IAW VASRD §4.97. The single voter for dissent (who
recommended no recharacterization of asthma at 10%) submitted the appended minority
opinion. There were no other conditions within the Board’s scope of review for consideration.
RECOMMENDATION: The Board recommends that the CI’s prior determination be modified as
follows and that the discharge with severance pay be recharacterized to reflect permanent
disability retirement, effective as of the date of her prior medical separation:
VASRD CODE
RATING
30%
30%
6602
COMBINED
UNFITTING CONDITION
Asthma
The following documentary evidence was considered:
Exhibit A. DD Form 294, dated 20120605, w/atchs
Exhibit B. Service Treatment Record
Exhibit C. Department of Veterans’ Affairs Treatment Record
XXXXXXXXXXXXXXXXXXX
President
Physical Disability Board of Review
MINORITY OPINION:
The minority voter agrees with the statement in the above proceedings that, “The key question
to the Board was whether there was reasonable doubt as to the CI’s severity based on
medication use.” The PEB rated the asthma condition at 10% based upon what they considered
insufficient evidence demonstrating that the CI was actually taking “the daily inhalational or
oral bronchodilator therapy, or; inhalational anti-inflammatory medication” as required by the
VASRD Code 6602 to reach the 30% rating. The PEB stated, “Asthma with CHCS/Pharmacy
record noting intermittent use - no medications from April 2003 until July 2003.” A review of
the pharmacy records in evidence validates the PEB’s observations. The board discussion
hinged upon the assumption that the CI “allegedly” received additional asthma medications and
refills from his non-military physician during the aforementioned period of April 2003 until July
2003. This explanation falls short in that if the civilian prescriptions were not filled at the
military facility (the more logical course of action from a personal financial perspective, and one
that would have been captured by the evidence at hand); then civilian pharmacy records would
logically have been presented to refute the PEB finding. Likewise it is unreasonably speculative
to conclude that all of the undispensed medications were garnered as physician office samples.
The minority voter believes that there is insufficient objective evidence and an overly
speculative rationale, even with liberal concession of reasonable doubt, to support the majority
conclusion which was the keystone for elevating the rating to 30%. The minority opinion was
apparently shared by the VA rating official who conferred a 10% rating. When challenged with
this argument, the majority response was that the rating official made an “error.” The minority
voter does not find enough benefit of the doubt to declare that the VA rating official was in
error, along with the members of the PEB.
The Secretary is respectfully urged to consider the minority recommendation that there be no
recharacterization of the CI’s disability and separation determination, as follows:
UNFITTING CONDITION
VASRD CODE RATING
6602
COMBINED
10%
10%
Asthma
DEPARTMENT OF THE ARMY
251 18TH STREET SOUTH, SUITE 385
ARMY REVIEW BOARDS AGENCY
ARLINGTON, VA 22202-3531
SFMR-RB
MEMORANDUM FOR Commander, US Army Physical Disability Agency
(TAPD-ZB / ), 2900 Crystal Drive, Suite 300, Arlington, VA 22202-3557
SUBJECT: Department of Defense Physical Disability Board of Review Recommendation for
XXXXXXXXXXXXXXXXXXX, AR20120021793 (PD201200621)
1. I have reviewed the enclosed Department of Defense Physical Disability Board of Review
(DoD PDBR) recommendation and record of proceedings pertaining to the subject individual.
Under the authority of Title 10, United States Code, section 1554a,
I reject the Board’s recommendation and accept the Board’s minority opinion as accurate that
the applicant’s final Physical Evaluation Board disability rating remains unchanged. There is
insufficient justification to support the Board’s recommendation in accordance with Army and
Department of Defense regulations.
2. This decision is final. The individual concerned, counsel (if any), and any Members of
Congress who have shown interest in this application have been notified of this decision by
mail.
BY ORDER OF THE SECRETARY OF THE ARMY:
Encl
CF:
( ) DoD PDBR
( ) DVA
XXXXXXXXXXXXXXXXXXXXXX
Deputy Assistant Secretary
(Army Review Boards)
Printed on Recycled Paper
AF | PDBR | CY2011 | PD2011-00618
The CI was thus medically separated with a 0% service disability rating. Asthma Condition . In the matter of the asthma condition, the Board unanimously recommends a rating of 60% during the prescribed period of TDRL; and, a permanent service disability rating of 10% coded 6602 IAW VASRD §4.97.
AF | PDBR | CY2013 | PD 2013 00908
SEPARATION DATE: 20040312 Asthma Condition . The diagnosis in his finding of unfitness for Asthma,VASRD Code 6602, was rated at 30% rather than 10%.
AF | PDBR | CY2011 | PD2011-00224
After 12 months of TDRL the asthma condition was considered to be stable, but still unfitting. The Board does not have the authority under DoDI 6040.44 to render fitness or rating recommendations for any conditions not considered by the DES. The Board therefore has no reasonable basis for recommending any additional unfitting conditions for separation rating.
AF | PDBR | CY2009 | PD2009-00263
The PEB’s DA Form 199 dated 20050413 indicated “Asthma, with normal spirometry, on intermittent inhalational bronchodilator therapy.” The PEB specified “Medication profile shows no controller medication between March – April 2004 and 15 February 2005.” The PEB permanent separation rating was 6602 at 10%; and the VASRD 10% criteria contains the phrasing “intermittent inhalational or oral bronchodilator therapy.” There is therefore no evidence that the provisions of DoDI 1332.39 were applied. ...
AF | PDBR | CY2013 | PD-2013-02765
The requested sleep apnea, anxiety, hypertension and rhinitis conditions were not identified by the PEB, and therefore not within the DoDI 6040.44 defined purview of the Board.Any conditions or contention not requested in this application, or otherwise outside the Board’s defined scope of review, remain eligible for future consideration by the Board for Correction of Military Records. Asthma Condition . The PEB TDRL exit rating was 10%,with the disability description stating: “not...
AF | PDBR | CY2013 | PD-2013-02334
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of theVASRD standards to the unfitting medical condition at the time of separation. The §4.97 criteria for a 30% rating are “FEV-1 of 56- to 70-percent predicted, or; FEV-1/FVC of 56 to 70 percent, or; daily inhalational or oral bronchodilator therapy, or; inhalational anti-inflammatory medication;” and, those for 10% are “FEV-1 of 71- to 80-percent...
AF | PDBR | CY2013 | PD2013 01411
RECORD OF PROCEEDINGSPHYSICAL DISABILITY BOARD OF REVIEWNAME: XXXXXXXXXXXXXXXXXX CASE: PD1301411 BRANCH OF SERVICE: Army BOARD DATE: 20140122 At that time a diagnosis of mild persistent asthma aggravated by exposure to petroleum products was rendered.At the separation exam on 17 November 2003, the CI reported using inhalers “when needed for asthma.”Review of the STR showed one note in evidence documenting the use of an oral steroid for asthma (September 2003).At a clinic visit for...
AF | PDBR | CY2012 | PD2012-00469
The CI was re-evaluated almost 14 months later and the PEB recommended removal of the CI from the TDRL with a permanent disability rating of 10%. The PEB initially utilized VASRD code 6602, asthma, and rated it 30% based on daily inhaled medications with normal PFTs and placed the CI on TDRL. I direct that all the Department of the Army records of the individual concerned be corrected accordingly no later than 120 days from the date of this memorandum: individual was separated by reason of...
AF | PDBR | CY2013 | PD-2013-01963
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of the VASRD standards to the unfitting medical condition at the time of separation. The Board next considered that at the time of separation, although the CI’s asthma was relatively well controlled,treatment notes in the STR, the MEB and C&P exams consistently documented use of the anti-inflammatory inhaler and oral bronchodilator medications, with...
AF | PDBR | CY2013 | PD-2013-01775
The commander’s letter reflected that the CI’s medical condition of asthma wouldpreclude him from further military service in a field situation.Although absent any VA C&P examination, a subsequent VARD indicated not service-connected (NSC) for a respiratory condition noting “…fail to show any follow-ups for your respiratory symptoms.” BOARD FINDINGS : IAW DoDI 6040.44, provisions of DoD or Military Department regulations or guidelines relied upon by the PEB will not be considered by the...